Trendlines Medical Singapore participates in new initiative, i2Start

Trendlines Medical Singapore CEO Eric Loh presented the incubator model at the launch of a new initiative, i2Start.

Backed by three government agencies — Singapore MIT Alliance Research Technology (SMART), National Health Innovation Centre (NHIC), and SPRING — i2Start provides a grant to clinician/institutional researcher-led projects with the aim of spinning off or commercializing the efforts. Eligible projects may receive up to SGD1.25 million.

Eric describes how the i2Start grant works:

  1. “Projects being developed by clinicians/institution researcher are eligible for submission. The key requirement is that there is intention for the project to be spun off into a privately held company. There is advantage if a commercial party works with the project team at the start.
  2. “When the project is approved by the i2Start panel, the first SGD250,000 will be disbursed from SMART. If the prescribed milestones are achieved, NHIC will disburse the additional SGD250,000. When the start-up company is formed, SPRING will disburse up to SGD750,000, reaching a total of SGD1.25 million for the project.”